Among the 13 cell types, GPR-score is highly expressed in CD8 + T cells of immune cells and in endothelial cells of non-immune cells, suggesting that GPR-score acts in BLCA mainly by affecting endothelial cells and CD8+ T cells (Figure 4e and f). Here, CD8A is linked to bladder transitional cell carcinoma.